Cambridge Investment Research Advisors, Inc. Veru Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.9 Billion
- Q4 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Veru Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 1,216,674 shares of VERU stock, worth $717,837. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,216,674
Previous 818,535
48.64%
Holding current value
$717,837
Previous $629,000
25.76%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VERU
# of Institutions
136Shares Held
56.7MCall Options Held
817KPut Options Held
595K-
Black Rock Inc. New York, NY7.65MShares$4.51 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY6.48MShares$3.83 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.22MShares$3.67 Million0.0% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.29MShares$2.53 Million0.42% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.76MShares$2.22 Million0.0% of portfolio
About VERU INC.
- Ticker VERU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 80,146,704
- Market Cap $47.3M
- Description
- Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....